[Federal Register Volume 74, Number 69 (Monday, April 13, 2009)]
[Notices]
[Pages 16871-16872]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-8398]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Advisory Committee on Blood Safety and 
Availability

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Advisory Committee on Blood Safety and Availability (ACBSA) will 
hold a meeting. The meeting will be open to the public.

DATES: The meeting will take place Thursday, April 30 and Friday, May 
1, 2009 from 9 a.m. to 5 p.m.

ADDRESSES: The Universities at Shady Grove, 9630 Gudelsky Drive, 
Rockville, MD 20850, Phone: 301-738-6000.

FOR FURTHER INFORMATION CONTACT: Jerry A. Holmberg, PhD, Executive 
Secretary, Advisory Committee on Blood Safety and Availability, Office 
of Public Health and Science, Department of Health and Human Services, 
1101 Wootton Parkway, Suite 250, Rockville, MD 20852, (240) 453-8803, 
FAX (240) 453-8456, e-mail [email protected].

SUPPLEMENTARY INFORMATION: The Advisory Committee on Blood Safety and 
Availability provides advice to the Secretary and the Assistant 
Secretary for Health on a range of policy issues that impact (1) 
definition of public health parameters around safety and availability 
of the blood supply and blood products, (2) broad public health, 
ethical and legal issues related to transfusion and transplantation 
safety, and (3) the implications for safety and the availability of 
various economic factors affecting product cost and supply. In keeping 
with its established mission, the ACBSA has been asked to explore 
processes and parameters which should be used in the decision-making 
process for transfusion and transplantation safety policy. At the April 
30 to May 1, 2009 meeting, the Committee will be asked to comment on 
evidenced-based, zero-risk, cost, benefit and comparative 
effectiveness, societal position or mandate, ethical, and stakeholders 
concerns.
    The public will have opportunity to present their views to the 
Committee on both meeting days. A public comment session has been 
scheduled for April 30 and May 1, 2009. Comments will be limited to 
five minutes per speaker and must be pertinent to the discussion. Pre-
registration is required for participation in the public comment 
session. Any

[[Page 16872]]

member of the public who would like to participate in this session is 
encouraged to contact the Executive Secretary at his/her earliest 
convenience. It is requested that those who wish to have printed 
material distributed to the Committee provide thirty (30) copies of the 
document to be distributed to the Executive Secretary, ACBSA, prior to 
close of business April 27, 2009. If it is not possible to provide 30 
copies of the material to be distributed, then individuals are 
requested to provide at a minimum one (1) copy of the document(s) to be 
distributed prior to the close of business April 27, 2009. It also is 
requested that any member of the public who wishes to provide comments 
to the Committee utilizing electronic data projection submit the 
necessary material to the Executive Secretary prior to close of 
business April 27, 2009.

    Dated: April 8, 2009.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on Blood Safety and 
Availability.
[FR Doc. E9-8398 Filed 4-10-09; 8:45 am]
BILLING CODE 4140-41-P